Bone Biologics (BBLGW) Other Working Capital Changes (2014 - 2025)

Bone Biologics (BBLGW) has reported Other Working Capital Changes for 11 consecutive years, with -$71347.0 the latest figure, recorded in Q3 2025.

• On a quarterly basis, Other Working Capital Changes rose 26.8% year-over-year to -$71347.0 in Q3 2025; TTM through Sep 2025 was -$32221.0, a 118.98% decrease from a year earlier, with the FY2024 full-year figure at -$104171.0, down 2052.6% from the prior year.
• Other Working Capital Changes was -$71347.0 for Q3 2025 at Bone Biologics, down from -$53757.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $438502.0 in Q4 2023 and troughed at -$361491.0 in Q1 2023.
• A 4-year average of $5428.6 and a median of -$71347.0 in 2025 frame the typical range for Other Working Capital Changes.
• Across the five-year window, Other Working Capital Changes jumped 126.49% in 2023 and slumped 463.44% in 2024, its largest moves.
• Over 4 years, Other Working Capital Changes stood at $235281.0 in 2022, then surged by 86.37% to $438502.0 in 2023, then plunged by 62.48% to $164529.0 in 2024, then slumped by 143.36% to -$71347.0 in 2025.
• The last three Other Working Capital Changes figures came in at -$71347.0 (Q3 2025), -$53757.0 (Q2 2025), and -$71646.0 (Q1 2025), per Business Quant data.